Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-27

FDA Approved: OXYTOCIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Oxytocin from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

SUPPL AP for OXYTOCIN (OXYTOCIN)